Impact of a 5-year antimicrobial stewardship program focusing on fluoroquinolone prescriptions

Int J Pharm Pract. 2021 Dec 4;29(6):616-621. doi: 10.1093/ijpp/riab047.

Abstract

Objectives: Within the context of the wide use of fluoroquinolones (FQs) and the emergence of multidrug-resistant bacteria, French recommendations concerning the appropriate use of systemic FQs in adults were published in 2015. This study assessed the impact of antibiotic stewardship intervention on the use of FQs over a 5-year period.

Methods: Five annual audits were performed to evaluate FQ prescriptions. Following the baseline audit, a campaign of appropriate antibiotic use was initiated with courses on antibiotics including FQs. All audits included quantitative and qualitative evaluations to calculate an index of therapeutic adequacy (ITA) with six criteria: indication, molecule type, dosage, duration, route of administration and association. These audits were performed annually from 2015 to 2019.

Key findings: The number of prescriptions decreased substantially from 90 in 2015 to 17 in 2019. This reduction was consistent with consumption data, such that the defined daily dose for 1000 bed days diminished from 67 in 2015 to 42 in 2019. Between 2015 and 2016, the ITA decreased significantly from 3.27 to 1.79 (P = 0.001), corresponding to an improvement in prescription quality. The ITA stabilised between 2016 and 2019. Moreover, improvements were observed in the proportion of entirely conforming prescriptions, conformity of indications, choice of molecule type among FQs and proportion of prescriptions with non-conforming treatment durations.

Conclusions: Between 2015 and 2019, we observed quantitative and qualitative improvements in FQ prescriptions within the hospital. Prescription follow-up through annual audits, combined with training courses, contributed to consistent results.

Keywords: anti-bacterial agents; antimicrobial stewardship; fluoroquinolones; rational antibiotic use.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship*
  • Drug Prescriptions
  • Fluoroquinolones
  • Hospitals
  • Humans
  • Prescriptions

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones